Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series

RATIONALE & OBJECTIVE: Neutralizing monoclonal antibody treatments have shown promising preliminary results in kidney transplant recipients infected with severe acute respiratory syndrome coronavirus 2. However, their efficacy in kidney transplant recipients infected with the Omicron variant has...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Guillaume, Devresse, Arnaud, Scohy, Anais, De Greef, Julien, Yombi, Jean Cyr, Belkhir, Leila, Darius, Tom, Mourad, Michel, Buemi, Antoine, Kabamba, Benoit, Goffin, Eric, Kanaan, Nada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042411/
https://www.ncbi.nlm.nih.gov/pubmed/35493029
http://dx.doi.org/10.1016/j.xkme.2022.100470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042411/
https://www.ncbi.nlm.nih.gov/pubmed/35493029
http://dx.doi.org/10.1016/j.xkme.2022.100470

Ejemplares similares